Free Trial

State Street Corp Sells 740,645 Shares of Enhabit, Inc. (NYSE:EHAB)

Enhabit logo with Medical background

State Street Corp lessened its position in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 38.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,161,697 shares of the company's stock after selling 740,645 shares during the period. State Street Corp owned approximately 2.31% of Enhabit worth $9,177,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Systematic Financial Management LP grew its holdings in shares of Enhabit by 12.2% during the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company's stock worth $14,522,000 after purchasing an additional 199,235 shares in the last quarter. Point72 DIFC Ltd bought a new position in shares of Enhabit in the 3rd quarter worth $108,000. Needham Investment Management LLC raised its position in shares of Enhabit by 42.9% during the 3rd quarter. Needham Investment Management LLC now owns 50,000 shares of the company's stock valued at $395,000 after buying an additional 15,000 shares in the last quarter. Atom Investors LP lifted its holdings in shares of Enhabit by 47.5% during the 3rd quarter. Atom Investors LP now owns 173,783 shares of the company's stock worth $1,373,000 after acquiring an additional 55,999 shares during the last quarter. Finally, Bardin Hill Management Partners LP grew its position in Enhabit by 927.4% in the third quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company's stock worth $1,377,000 after acquiring an additional 157,338 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on EHAB. Jefferies Financial Group upgraded Enhabit from a "hold" rating to a "buy" rating and raised their price target for the company from $8.25 to $9.50 in a research report on Monday, December 9th. Leerink Partners reissued a "market perform" rating and set a $8.00 price objective (down from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Enhabit has an average rating of "Hold" and an average price target of $8.75.

Read Our Latest Stock Report on Enhabit

Enhabit Trading Down 0.6 %

NYSE EHAB traded down $0.05 during trading on Friday, hitting $7.68. 217,867 shares of the company's stock traded hands, compared to its average volume of 563,240. The stock has a fifty day moving average of $7.67 and a two-hundred day moving average of $8.23. Enhabit, Inc. has a 12-month low of $6.85 and a 12-month high of $11.74. The firm has a market cap of $386.18 million, a P/E ratio of -3.31 and a beta of 1.89. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46.

Enhabit (NYSE:EHAB - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The company had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. During the same quarter in the previous year, the business earned $0.03 earnings per share. As a group, sell-side analysts expect that Enhabit, Inc. will post 0.22 EPS for the current year.

Insider Buying and Selling

In other Enhabit news, Director Jeffrey Bolton acquired 4,000 shares of the business's stock in a transaction dated Thursday, December 12th. The shares were purchased at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the transaction, the director now owns 98,144 shares in the company, valued at $852,871.36. This represents a 4.25 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Stuart M. Mcguigan bought 15,000 shares of Enhabit stock in a transaction dated Tuesday, December 10th. The shares were acquired at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the completion of the purchase, the director now directly owns 46,810 shares of the company's stock, valued at approximately $412,396.10. This trade represents a 47.15 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is owned by insiders.

Enhabit Company Profile

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Recommended Stories

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Should You Invest $1,000 in Enhabit Right Now?

Before you consider Enhabit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.

While Enhabit currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines